Related Experiment Video
Updated: May 18, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Published on: July 18, 2025
Metabolic Dysfunction Associated Steatohepatitis (MASH) in Oceania, Central America, and the Caribbean
Stuart Keith Roberts1, Luis Antonio Díaz2, Marlen Ivon Castellanos-Fernández3
1Department of Gastroenterology, Alfred Health, Prahran, Australia; Central Clinical School, Monash University, Clayton, Australia.
Abstract:
Metabolic dysfunction-associated steatotic liver disease and its progressive form, metabolic dysfunction-associated steatohepatitis, are expanding across Australia, Central America, and the Caribbean, driven by obesity, diabetes, and social disadvantage. The authors synthesize contemporary epidemiology, highlighting rising prevalence, projected surges in advanced disease and mortality, and heterogeneity by most relevant sociodemographic characteristics. They outline pragmatic, resource-adaptable care pathways that begin with Fibrosis-4 in primary care and escalate to elastography or direct fibrosis biomarkers, noting access bottlenecks outside metropolitan hubs and smaller islands. They summarize models of care-multidisciplinary and nurse-led clinics and mobile and community-health worker programs-and emphasize lifestyle modification.
Related Concept Videos
Inborn Errors of Metabolism
Hepatic Encephalopathy
Cirrhosis II: Pathophysiology
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Chronic Pancreatitis II: Pathophysiology
